Zynex Reports Q1 2025: Revenue Plummets 43% Amid Rising Losses and Operational Challenges

Zynex, Inc. (OTCMKTS: ZYXI) reported its financial results for the first quarter of 2025, showcasing a challenging period marked by significant revenue decline and increased operational challenges.

Key Highlights:

• Net Revenue: $26.6 million, down 43% from $46.5 million in Q1 2024.
• Net Loss: $10.4 million compared to net income of $10,000 in Q1 2024.
• Cash Position: $23.9 million in cash and cash equivalents as of March 31, 2025.
• Operating Loss: Income (loss) from operations was $(13.1) million, reflecting increased costs and lower revenue.
• Sales Reduction: Device revenue decreased to $11.9 million from $14.0 million; supplies revenue dropped to $14.7 million from $32.5 million.
• Staff Reduction: The company has reduced its workforce by 15% to align with current revenues.

Positive Aspects:

• The company continues to adapt operationally by implementing staff reductions, which are expected to save approximately $35 million annually.
• Goodwill remains stable at $20.4 million, indicating the company’s consistent asset value post-acquisition of Kestrel Labs.
• Reduction in inventory from $13.9 million to $13.5 million suggests improved inventory management amidst declining sales.

Negative Aspects:

• The TriCare payment suspension has significantly impacted revenue, as it accounts for 20-25% of annual revenue.
• Cost of revenue increased to 31% of net revenue due to decreased sales performance, raising operational efficiency concerns.
• General and administrative expenses rose by 8%, highlighting operational inefficiencies despite revenue decline.
• Negative cash flow from operations of $(10.5) million contrasts sharply with the positive flow of $2.1 million in the previous year.

Looking Ahead:

Management is working on increasing efficiency and securing payment reinstatement from Tricare, which is crucial for restoring revenue stability. The company is focused on improving sales force productivity following significant layoffs. Additionally, Zynex, Inc. aims to leverage its cash reserves and streamline costs for better financial health in the coming quarters.